Chinese Firm Reportedly Nets $18 Million in 'Questionable' Token Sale
Despite China's 2017 ban on ICOs, a Chinese firm still appears to have openly promoted a token sale that reportedly raised $18 million.
A Chinese healthcare firm has reportedly raised 120 million yuan ($18 million) by issuing a custom cryptocurrency, despite China's 2017 ban on initial coin offerings (ICOs).
According to the posts, Zhaoyun Group targeted the issuance of 170 million of its own ERC-20-based (an ethereum standard) tokens, dubbed Trillion Cloud Gold (TGCG), 10 percent of which were sold through a public offering.
from etherscan.io, the website that tracks transactions on the ethereum blockchain, shows that all the tokens were created in mid-March 2018, but that no transactions were made thereafter.
Through conversations with promotors in the token sale's WeChat groups, the report indicated that the public offering raised the $18 million through a tiered distribution system wherein members receive a return on their investment by attracting additional investors to purchase the token.
The report went on to call the firm's conduct "questionable," given that it could have violated China's notable ban on ICOs, while the firm's business model appears to "very similar" those seen in pyramid and Ponzi schemes.
The reported ICO comes at a time when Chinese authorities have stepped up its efforts in cracking down on crypto-related fundraising activities, as well as on those that use the concept to fleece investors through pyramid schemes, as previously reported by CoinDesk.
At press time, Zhaoyun Group had not responded to a CoinDesk request for comment.
Marbles image via Shutterstock
The leader in news and information on cryptocurrency, digital assets and the future of money, CoinDesk is a media outlet that strives for the highest journalistic standards and abides by a strict set of editorial policies. CoinDesk is an independent operating subsidiary of Digital Currency Group, which invests in cryptocurrencies and blockchain startups. As part of their compensation, certain CoinDesk employees, including editorial employees, may receive exposure to DCG equity in the form of stock appreciation rights, which vest over a multi-year period. CoinDesk journalists are not allowed to purchase stock outright in DCG.
Learn more about Consensus 2024, CoinDesk’s longest-running and most influential event that brings together all sides of crypto, blockchain and Web3. Head to consensus.coindesk.com to register and buy your pass now.